“bluebird-bio” Archives

Entry Author Date Location
Fred Hutch Team Wants To Move Clean-Room Gene Therapy To Tabletop 10/20/16 Seattle
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
With Upgraded Tech, Bluebird Updates Regulatory Path For Gene Therapy 10/13/16 Boston
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
Across The Board: Ideas To Narrow Biotech’s Gender Gap 05/10/16 National
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
Bluebird’s Gene Therapy Shows Promise in Rare Brain Disease 04/20/16 Boston
Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara 04/14/16 Boston
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
UniQure’s Shares Rise on Early Gene Therapy Data For Hemophilia 01/07/16 National
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio 11/19/15 San Diego
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
New Bluebird Data Hint at Gene Therapy’s Limits For Some Patients 11/05/15 Boston
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
Page 1 of 5 next page »